ADAMTS5 is a biomarker for prediction of response to infliximab in patients with rheumatoid arthritis

Kensei Tsuzaka, Yuka Itami, Tsutomu Takeuchi, Naoshi Shinozaki, Tetsuo Morishita

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ADAMTS5 is a biomarker for prediction of response to infliximab in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences